一个5年更新的临床开发基于癌细胞的质母细胞多形瘤疫苗的临床发展

Almohanad A Alkayyal1, Ahmad Bakur Mahmoud2,3

  • 1Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.

概括

基于细胞的疫苗对多种质母细胞瘤 (GBM) 治疗有前途,可能提高生存率. 个性化免疫疗法和患者分层是克服GBM的关键.